Lack of long-term protective effect of antioxidant/anti-inflammatory therapy in transplant-induced ischemia/reperfusion injury

American Journal of Nephrology

Volumn 26, Issue 3, 2006, Pages 213-217

  Tain, You Lin ^a   Muller, Veronika ^b   Szabo, Attila ^b   Dikalova, Anna ^c   Griendling, Kathy ^c   Baylis, Chris ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant; Ischemia reperfusion; Kidney transplant; Nitric oxide

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ARGININE; DEFEROXAMINE; DEXAMETHASONE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIUM; ENZYME ACTIVITY; FEMALE; ISOGRAFT; KIDNEY CORTEX; KIDNEY DONOR; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REPERFUSION INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; RATS; RATS, INBRED F344; REPERFUSION INJURY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33746364154     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093587     Document Type: Article

References (15)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342:605-612.
2. Halloran PF, Homik J, Goes N, Lui SL, Urmson J, Ramassar V, Cockfield SM: The 'injury response': a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997;29:79-81.
3. Perico N, Cattaneo D, Sayegh MH, Remuzzi G: Delayed graft function in kidney transplantation. Lancet 2004;364:1814-1827.
4. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D: Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135-159.
5. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C: Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 2000;58:658-673.
6. Huang H, He Z, Roberts LJ 2nd, Salahudeen AK: Deferoxamine reduces cold-ischemic renal injury in a syngeneic kidney transplant model. Am J Transplant 2003;3:1531-1537.
7. Chander V, Chopra K: Renal protective effect of molsidomine and L-arginine in ischemia-reperfusion induced injury in rats. J Surg Res 2005;128:132-139.
8. Erdely A, Wagner L, Muller V, Szabo A, Baylis C: Protection of Wistar Furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase. J Am Soc Nephrol 2003;14:2526-2533.
9. Szabo AJ, Wagner L, Erdely A, Lau K, Baylis C: Renal neuronal nitric oxide synthase protein expression as a marker of renal injury. Kidney Int 2003;64:1765-1771.
10. Hanna IR, Hilenski LL, Dikalova A, Taniyama Y, Dikalov S, Lyle A, Quinn MT, Lassegue B, Griendling KK: Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med 2004;37:1542-1549.
11. Dikalov SI, Dikalova AE, Mason RP: Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine. Arch Biochem Biophys 2002;402:218-226.
12. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL: Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation 1997;64:190-197.
13. Kouwenhoven EA, de Bruin RW, Heemann U, Marquet RL, Ijzermans JN: Does cold ischemia induce chronic kidney transplant dysfunction? Transplant Proc 1999;31:988-989.
14. Reutzel-Selke A, Zschockelt T, Denecke C, Bachmann U, Jurisch A, Pratschke J, Schmidbauer G, Volk HD, Neuhaus P, Tullius SG: Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/reperfusion injury and long-term graft function in renal allografts from older donors. Transplantation 2003;75:1786-1792.
15. Schramm L, La M, Heidbreder E, Hecker M, Beckman JS, Lopau K, Zimmermann J, Rendl J, Reiners C, Winderl S, Wanner C, Schmidt HH: L-Arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. Kidney Int 2002;61:1423-1432.